Tissue expression of SKA1 (Spindle kinetochore-associated complex 1) in oral cancers and oral potentially malignant disorders: An association with disease progression
Journal of the Pakistan Medical Association · 26.03.2026 · 76 (04) · 546-550
DOI: 10.47391/jpma.22972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 26.03.2026. Verfasst von Samreen Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Chromosomal Proteins, Non-Histone, Carcinoma, Squamous Cell, Squamous Cell Carcinoma of Head and Neck. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine the tissue expression of spindle kinetochore-associated complex sub-unit 1 in both oral squamous cell carcinomas and oral potentially malignant disorders, and to evaluate its association with the two lesions.
Method
The analytical, cross-sectional study was conducted at Dow University of Health Sciences, Karachi, and comprised clinically and histopathological confirmed biopsy samples of oral squamous cell carcinoma and oral dysplasia that were collected from the Otolaryngology ward/outpatient department of Dr Ruth Pfau Civil Hospital Karachi, Dr Ishrat-ul-Ebad Khan Institute of Oral Health Sciences, Karachi, and the histopathology section of Dow Diagnostic Reference and Research Laboratory, Karachi, during July 2022 and April 2023. Detailed clinical history as well as radiological and histopathological findings were noted. Tissue expression of spindle kinetochore-associated complex sub-unit 1 was analysed on the samples through immunohistochemistry. Data was analysed using SPSS 21.
Results
Of the 90 cases, 45(50%) had oral squamous cell carcinoma; 34(75.6%) males, 11(24.4%) females, 24(53.3%) aged 50 years. The remaining 45(50%) cases had oral potentially malignant disorders; 35(77.8%) males, 10(22.2%) females, 24(53.3%) aged 50 years. Tissue expressions of spindle kinetochore-associated complex sub-unit 1 were strongly positive in 25(55.6%) cases of oral squamous cell carcinoma and 13(28.9%) cases of oral potentially malignant disorders. Moderately positive expressions were seen in 20(44.4%) cases of oral squamous cell carcinoma and 32(71.1%) cases of oral potentially malignant disorders (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
- Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan.
- 5Department of Otolaryngology, Dr. Ruth Pfau Civil Hospital, Dow University of Health and Sciences, Karachi, Pakistan.
- Department of Otolaryngology, Dr. Ruth Pfau Civil Hospital, Dow University of Health and Sciences, Karachi, Pakistan.
Zitieren
APA
Khan, S., Alamgir, M. M., Bukhari, U., Farrukh, M. S., & Quratulain (2026). Tissue expression of SKA1 (Spindle kinetochore-associated complex 1) in oral cancers and oral potentially malignant disorders: An association with disease progression. Journal of the Pakistan Medical Association, 76(04), 546-550. https://doi.org/10.47391/jpma.22972
Vancouver
Khan S, Alamgir MM, Bukhari U, Farrukh MS, Quratulain. Tissue expression of SKA1 (Spindle kinetochore-associated complex 1) in oral cancers and oral potentially malignant disorders: An association with disease progression. Journal of the Pakistan Medical Association. 2026;76(04):546-550. doi:10.47391/jpma.22972
BibTeX
@article{Khan2026,
author = {Khan, Samreen and Alamgir, Muhammad Mohiuddin and Bukhari, Uzma and Farrukh, Muhammad Shuja and Quratulain, Quratulain},
title = {Tissue expression of SKA1 (Spindle kinetochore-associated complex 1) in oral cancers and oral potentially malignant disorders: An association with disease progression},
journal = {Journal of the Pakistan Medical Association},
year = {2026},
volume = {76},
number = {04},
pages = {546--550},
doi = {10.47391/jpma.22972}
}
EUVIMED